Treatment with Tecentriq 840mg Injection: Innovative Approach to Therapy

Tecentriq 840mg Injection

Description

• Contains the active ingredient Atezolizumab.
• Belongs to the class of medicine called monoclonal antibody (Mab).
• Used to treat cancer in the bladder, lungs, liver, and breast.
• Used as adjuvant therapy (treatment after surgery) for lung cancer conditions where the cancer is not spread to other body parts.

Uses

• Urothelial carcinoma
• Non-small cell lung cancer
• Small cell lung cancer
• Triple-negative breast cancer
• Hepatocellular carcinoma

Mechanism of Action

• Atezolizumab blocks the interaction between PD-L1 and PD-1, helping T-cells recognize and attack cancer cells more effectively.
• Stimulates the immune system to attack cancer cells and potentially slow down or stop cancer growth.

Contraindications

• Do not take if you are allergic to Atezolizumab or other medicine ingredients.
• Not recommended for children and adolescents.

Before Taking

• Inform your doctor if you have or ever had an autoimmune disease, HIV infection or AIDS, pneumonitis, infections like HIV/AIDS, a chronic viral infection of the liver (hepatitis B / hepatitis C).
• Notify if you have been given any live, attenuated vaccine, antibiotic within the two weeks, or any medicine to improve or suppress your immune system.
• Report if you are pregnant or planning to get pregnant.

Interaction with Other Drugs

• Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional, supplements, and herbal products.
• Certain medications may interact with Tecentriq 840mg and reduce its effectiveness by causing undesirable side effects.

Storage

• Store Tecentriq 840mg in the refrigerator (2°C to 8°C).
• Do not freeze.
• Keep the injection away from the reach of children and pets.

Administration

• A trained doctor or nurse should only administer it.
• Do not self-administer the injection.
• Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors.
• Given as an intravenous infusion, and you will be monitored carefully for unwanted side effects.

Safety Advices

• Pregnancy: Your doctor will prescribe Tecentriq 840mg only if needed, as this medicine might cause harm to the unborn baby.
• Breast Feeding: It is unknown whether Tecentriq 840mg is safe to administer in breastfeeding patients.
• Lungs: Inform your physician about any underlying lung disorders before taking Tecentriq 840mg.
• Liver: Inform your physician about any underlying liver disorders before taking Tecentriq 840mg.
• Alcohol: It is unknown whether it is safe to consume alcohol with Tecentriq 840mg as this medicine makes you feel drowsy.
• Driving: It is unsafe to drive while taking Tecentriq 840mg because this medicine might cause minor influence, so avoid driving and operating machinery during this treatment.

Side Effects

• Serious: Inflammation (lung, liver, intestine, thyroid, adrenal glands, and pituitary gland), Type 1 diabetes, inflammation of the brain, heart muscle, kidney, muscle, severe skin reaction, inflammation of problem with nerve.
• Common: Fever, loss of appetite, urinary tract infection, pain in the joints, muscles, and bones, headache, hair loss, numbness in hands and feet, sensitivity to sun, constipation, low oxygen level, high blood sugar, pain in stomach, mouth, and throat.

FAQs

• Q 1. Is Tecentriq 840mg chemotherapy medicine?
  • No, it is not a type of chemotherapy. Tecentriq 840mg is a monoclonal antibody, a type of immunotherapy medication that works by stimulating the body’s immune system to attack cancer cells.
• Q 2. What is the Tecentriq 840mg brand name?
  • Tecentriq 840mg is marketed under the brand name "Tecentriq."
• Q 3. Can Tecentriq 840mg be used in combination with other cancer treatments?
  • Yes, Tecentriq 840mg is often used with other anticancer medicine to treat certain types of cancer.
• Q 4. How long can you stay on immunotherapy?
  • Many people stay on immunotherapy for about two years. The duration of immunotherapy depends on the stage of cancer and how well one responds to the treatment.
• Q 5. What type of cancers does Tecentriq 840mg treat?
  • Tecentriq 840mg is prescribed to treat urothelial carcinoma, liver cancer (hepatocellular carcinoma), small cell and non-small cell lung cancer, triple-negative breast cancer, and melanoma.

Fact Box

• Molecule name: Atezolizumab
• Therapeutic class: Antineoplastics
• Pharmacological class: Monoclonal antibody
• Indications:
  • Urothelial carcinoma
  • Non-small cell lung cancer
  • Small cell lung cancer
  • Triple-negative breast cancer
  • Hepatocellular carcinoma

Теги: cancer_treatment, oncology, medicine, injection, drug, pharmaceutical, tecentriq, chemotherapy